Periodic Reporting for period 1 - NeMoFoil (NeMoFoil: electronic foil for neuromonitoring)
Reporting period: 2016-01-01 to 2017-06-30
Socioeconomic potential: From the market trends analysis, we concluded that the outpatient seizure detection for surveillance monitoring is the most potential market. Also, as a result from the epilepsy interviews with experts in this field it is found that inside the epilepsy market NeMofoil creates the most value as an outpatient seizure detection device for surveillance monitoring over the other potential markets, EMU and outpatient diagnosing. For the brain computer interface (BCI) market it is more challenging to determine the value of NeMoFoil as this market is not yet (commercially) established, and intracranial BCI performance requirements are yet unknown. In other words, the BCI-market is still in its very early development phase. Based on this we focus on outpatient seizure detection for surveillance monitoring, with possibilities to expand to BCI market on the long term.
1st target market, 5-7 years: Outpatient seizure detection for surveillance monitoring
2nd target market, 7+ years: BCI–intracranial brain-machine interface